Suppr超能文献

美国西部牛源奥斯特泰勒线虫和奥氏奥斯特线虫对大环内酯类驱虫药的抗药性。

Anthelmintic resistance of Ostertagia ostertagi and Cooperia oncophora to macrocyclic lactones in cattle from the western United States.

机构信息

Research Department, Johnson Research LLC, 24007 Highway 20-26, Parma, ID 83660, USA.

出版信息

Vet Parasitol. 2010 Jun 24;170(3-4):224-9. doi: 10.1016/j.vetpar.2010.02.036. Epub 2010 Mar 3.

Abstract

In June 2008, 122 yearling heifers with a history of anthelmintic resistance were obtained from pastures in northern California and transported to a dry lot facility in southwestern Idaho, USA. Fifty heifers with the highest fecal egg counts were selected for study enrollment. Candidates were equally randomized to treatment with either injectable ivermectin (Ivomec, Merial, 0.2 mg kg(-1) BW), injectable moxidectin (Cydectin), Fort Dodge, 0.2 mg kg(-1) BW), oral fenbendazole (Safe-Guard), Intervet, 5.0 mg kg(-1) BW), oral oxfendazole (Synanthic), Fort Dodge, 4.5 mg kg(-1) BW), or saline. At 14 days post-treatment, nematodes were recovered from the abomasum, small intestine, and large intestine. Parasitism was confirmed in the control group when 10/10 animals were infected with adult Ostertagia ostertagi and 9/10 animals with both developing and early L(4) stages of O. ostertagi. Similarly, 9/10 animals were parasitized with adult Cooperia spp. Fenbendazole and oxfendazole efficacy verses controls were >90% against adult Cooperia spp., while moxidectin caused an 88% parasite reduction post-treatment (P<0.05). Ivermectin treatment resulted in no reduction in adult Cooperia spp. Based on geometric mean percent reduction versus saline controls, all four treatments were >or=90% efficacious against adults of O. ostertagi, while moxidectin and fenbendazole were equally effective against developing and inhibited early L(4) stages (P<0.05). Ivermectin was not efficacious for developing or inhibited early L(4) stages of O. ostertagi. Oxfendazole failed to decrease O. ostertagi developing L(4) larvae by >90% but was efficacious for inhibited early L(4) larvae. Based on the results of this study, a source of multi-species anthelmintic resistance in cattle has been identified in the western United States.

摘要

2008 年 6 月,从加利福尼亚州北部的牧场获得了 122 头有驱虫药耐药史的一岁小母牛,并将它们运往美国西南部的爱达荷州的一个干堆场。从粪便卵计数最高的 50 头小母牛中选择进行研究登记。候选者被平均随机分为以下治疗组:伊维菌素(伊维菌素,默沙东,0.2mg/kg BW)、莫昔克丁(赛福丁,福陆达,0.2mg/kg BW)、芬苯达唑(安保,国际兽用保健品有限公司,5.0mg/kg BW)、奥芬达唑(辛可尼,福陆达,4.5mg/kg BW)或生理盐水。在治疗后 14 天,从瘤胃、小肠和大肠中回收线虫。当 10/10 只动物感染了成年 ostertagia ostertagi 并且 9/10 只动物同时感染了正在发育和早期 L(4)阶段的 ostertagia ostertagi 时,对照组的寄生虫病得到了确认。同样,9/10 只动物被成虫 Cooperia spp. 寄生。芬苯达唑和奥芬达唑对 Cooperia spp. 的疗效大于 90%,而莫昔克丁治疗后寄生虫减少 88%(P<0.05)。伊维菌素治疗对成年 Cooperia spp. 没有降低作用。基于与生理盐水对照的几何均数减少百分比,所有四种治疗方法对 ostertagia ostertagi 的成虫均有>90%的疗效,而莫昔克丁和芬苯达唑对发育中和早期 L(4)阶段的抑制同样有效(P<0.05)。伊维菌素对 ostertagia ostertagi 的发育或早期 L(4)阶段没有疗效。奥芬达唑未能将 ostertagia ostertagi 的发育 L(4)幼虫减少>90%,但对抑制早期 L(4)幼虫有效。基于这项研究的结果,在美国西部已经确定了一种牛多物种驱虫药耐药的来源。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验